Provided by Tiger Trade Technology Pte. Ltd.

CervoMed

3.28
+0.10003.14%
Post-market: 3.28-0.0050-0.15%19:50 EDT
Volume:341.95K
Turnover:1.11M
Market Cap:49.59M
PE:-1.03
High:3.31
Open:3.15
Low:3.13
Close:3.18
52wk High:10.00
52wk Low:2.13
Shares:15.12M
Float Shares:9.60M
Volume Ratio:0.93
T/O Rate:3.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1959
EPS(LYR):-2.9824
ROE:-107.62%
ROA:-60.80%
PB:2.16
PE(LYR):-1.10

Loading ...

CervoMed shareholders approve Amendment No. 1 to 2025 equity incentive plan at annual meeting

Reuters
·
Jun 09

H.C. Wainwright Reaffirms Their Buy Rating on CervoMed (CRVO)

TIPRANKS
·
Jun 09

CervoMed Highlights Q1 Results and Neflamapimod Progress

TIPRANKS
·
May 19

CervoMed price target lowered to $9 from $11 at Roth Capital

TIPRANKS
·
May 19

CervoMed posts smaller-than-expected Q1 net loss

Reuters
·
May 18

CervoMed Inc - Plans to Initiate Phase 3 Trial Evaluating Neflamapimod in Patients With Dlb in the Second Half of 2026

THOMSON REUTERS
·
May 18

CervoMed Q1 Net Income USD -8 Million VS. Ibes Estimate USD -9.03 Million

THOMSON REUTERS
·
May 18

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
May 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 18

Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and CervoMed (CRVO)

TIPRANKS
·
May 18

CervoMed Q1 EPS $(0.86) Misses $(0.78) Estimate

Benzinga Earnings
·
May 16

Top News Today: Stocks Slide, Treasury Yields Rise on Strait, Inflation Fears

Dow Jones
·
May 16

CervoMed Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Cervomed Q1 FY26 net loss widens 63% to $7.96 million

Reuters
·
May 15

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 15

CervoMed Inc expected to post a loss of 78 cents a share - Earnings Preview

Reuters
·
May 09

CervoMed announces annual shareholder meeting webcast

Reuters
·
Apr 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cochlear (OtherCHEOF), CervoMed (CRVO) and Community Health (CYH)

TIPRANKS
·
Apr 24

CervoMed Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 23

Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed

TIPRANKS
·
Apr 23